Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 USD | +1.64% | -0.80% | -17.33% |
May. 08 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 112M |
---|---|---|---|---|---|
Net income 2024 * | -99M | Net income 2025 * | -100M | EV / Sales 2024 * | - |
Net cash position 2024 * | 33.12M | Net Debt 2025 * | 55.55M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.25
x | P/E ratio 2025 * |
-1.41
x | Employees | 80 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.28% |
Latest transcript on Immunic, Inc.
1 day | +1.64% | ||
1 week | -0.80% | ||
1 month | -1.59% | ||
3 months | -15.36% | ||
6 months | +4.20% | ||
Current year | -17.33% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Vitt
CEO | Chief Executive Officer | 55 | 16-12-31 |
Glenn Whaley
DFI | Director of Finance/CFO | 56 | 19-11-30 |
Hella Kohlhof
CTO | Chief Tech/Sci/R&D Officer | 51 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barclay Phillips
BRD | Director/Board Member | 61 | 19-11-18 |
Tamar Howson
BRD | Director/Board Member | 75 | 19-10-10 |
Jörg Neermann
BRD | Director/Board Member | 57 | 19-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.24 | +1.64% | 152,304 |
24-05-30 | 1.22 | -0.81% | 109,622 |
24-05-29 | 1.23 | -1.60% | 132,383 |
24-05-28 | 1.25 | -.--% | 157,752 |
24-05-24 | 1.25 | +0.81% | 115,127 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.33% | 112M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- IMUX Stock